Across TCGA pan-cancer cohorts, HMX3 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated HMX3 data layer compared with 24 for mass-spec protein.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher HMX3 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated HMX3 expression acts as an unfavorable survival marker.

STAD are the cancer types where HMX3 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	All	0.003	0.688	<.001	36	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: HMX3 tumor-vs-normal RNA expression · all HMX3 data types